Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.
about
Brimonidine in the treatment of glaucoma and ocular hypertensionThe management of glaucoma and intraocular hypertension: current approaches and recent advancesMyelination transition zone astrocytes are constitutively phagocytic and have synuclein dependent reactivity in glaucoma.Modeling glaucoma in rats by sclerosing aqueous outflow pathways to elevate intraocular pressureReal-time imaging of single nerve cell apoptosis in retinal neurodegeneration.Randomised controlled trial comparing the effect of brimonidine and timolol on visual field loss after acute primary angle closure.A mouse model of elevated intraocular pressure: retina and optic nerve findingsAdaptive optics scanning laser ophthalmoscopy for in vivo imaging of lamina cribrosa.Agmatine protects retinal ganglion cells from hypoxia-induced apoptosis in transformed rat retinal ganglion cell line.Laser-induced chronic ocular hypertension model on SD rats.Effect of CNTF on retinal ganglion cell survival in experimental glaucomaGlaucoma alters the circadian timing system.Current concepts in the pathophysiology of glaucomaFunctional and morphological effects of laser-induced ocular hypertension in retinas of adult albino Swiss mice.Brimonidine is neuroprotective against glutamate-induced neurotoxicity, oxidative stress, and hypoxia in purified rat retinal ganglion cells.Retinal ganglion cell loss in a rat ocular hypertension model is sectorial and involves early optic nerve axon loss.A Review of Current and Future Management of Geographic Atrophy.Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neuronsElevated albumin in retinas of monkeys with experimental glaucoma.Brimonidine prevents neurodegeneration in a mouse model of normal tension glaucoma.Glaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancementOptic neuropathy due to microbead-induced elevated intraocular pressure in the mouse.Mouse models of retinal ganglion cell death and glaucoma.Brimonidine protects against loss of Thy-1 promoter activation following optic nerve crush.Disease progression in iridocorneal angle tissues of BMP2-induced ocular hypertensive mice with optical coherence tomography.Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure.Effects of ocular hypertension in the visual system of pigmented miceMeta-analysis of randomised controlled trials comparing latanoprost with brimonidine in the treatment of open-angle glaucoma, ocular hypertension or normal-tension glaucoma.Neuroprotection by α2-Adrenergic Receptor Stimulation after Excitotoxic Retinal Injury: A Study of the Total Population of Retinal Ganglion Cells and Their Distribution in the Chicken Retina.Human ganglion cells express the alpha-2 adrenergic receptor: relevance to neuroprotection.Astrocyte Structural and Molecular Response to Elevated Intraocular Pressure Occurs Rapidly and Precedes Axonal Tubulin Rearrangement within the Optic Nerve Head in a Rat Model.Recent advances in the management of dry age-related macular degeneration: A review.Expansions of the neurovascular scleral canal and contained optic nerve occur early in the hypertonic saline rat experimental glaucoma model.Neurotrophin roles in retinal ganglion cell survival: lessons from rat glaucoma models.A Period of Controlled Elevation of IOP (CEI) Produces the Specific Gene Expression Responses and Focal Injury Pattern of Experimental Rat GlaucomaControl of intracellular calcium signaling as a neuroprotective strategyPathophysiology of human glaucomatous optic nerve damage: insights from rodent models of glaucoma.Critical assessment of implantable drug delivery devices in glaucoma management.Imaging apoptosis in the eye.Protecting retinal ganglion cells.
P2860
Q22305848-B1939BE6-A7DC-4122-99AC-F36E38C134AFQ22305849-D1C3D353-9035-4828-8A10-4254EE6C16F3Q30497967-6FD9BD21-1B5C-445E-AC97-F3D79FC92BC2Q30671362-D079F933-CFF9-42A8-8D7A-2A48D93086CCQ30832375-CDB785B8-57A9-4315-9595-CBB32183AABEQ31034224-A499B199-6C3F-4DDD-A68F-B89F0578C204Q31048568-9FD7D03A-3841-4424-AC9A-6E5AD7F19FF8Q33281888-FD30EF48-71F3-4B92-A3C8-FDAE4B58C44CQ33301067-DAEFAC8F-1B67-4B46-BFD6-75ADE6128899Q33383220-8F63ABC1-3B9E-4594-B56B-203B7738FA91Q33390314-A066AFE6-02FB-46C5-B3CA-2034DE8905C5Q33392705-293D869B-8540-4043-BCE8-A95DB99AAF0EQ33477806-3DB730A1-079F-483E-8915-D6CD6AFDA6E6Q33518577-9557A9D9-5440-4AE7-962F-26A7EE50BF56Q33655845-4289F3A9-D424-4D2C-A184-3172B42A1FC0Q33681832-1C59A09C-B1A9-4151-81AE-294EAFA1FBF3Q33740158-330C844E-6BF0-4340-89E4-B0C6703FC721Q33792600-EF2BAC85-E99F-4603-BB52-7B18D298C861Q33845419-F8C5AFC8-22C0-4586-9C9E-493C93FACD33Q34007825-A8511778-26AB-4569-BEFC-C041E9CFCBB9Q34255732-50E3B4F2-E362-492C-A968-0922566B5F7FQ34646704-D7705A18-C042-4704-BBF1-2C9F13E3E3DBQ34664035-95C96E0A-C938-4D66-B37C-690826BC437FQ34785848-1BB68E36-0E25-4495-A928-72C1698FA6D2Q34787079-532239BC-C89C-4352-8FCF-F7D9C022EC9EQ34996623-E729D3E7-2587-4117-A8D8-AFEA9A10ACFDQ35587405-0CE34696-F27E-4719-8196-D51A0B9942DAQ35762849-B3FCCBC3-D191-40EC-90E1-A378E556BA5AQ36128064-F536A8B0-3FD7-4113-AC2A-8B7C0DCB8BFAQ36143732-B6418EA2-AEC0-4752-ADAD-DAD06F8DA041Q36205686-D9850998-609D-428D-AA35-6A4FA8994613Q36377333-D1CFE0C9-B177-48FA-AD70-E33BE31D96F0Q36827480-AEEA652B-1006-49BE-8117-29387DEF44CCQ37393418-B0F32469-DE3C-49D9-9F6D-FDAFCD99338BQ37503379-8A5D05CD-3D96-49DA-8767-67D822D39DDBQ37718540-6169A54D-FDCF-4389-A364-14E557AC7DD3Q37779827-CE074E5C-39D2-4BCE-93E5-2E9749A06FB1Q38143069-0B70E1B1-D77C-4862-9E20-D2D41C331028Q38375518-63EBE95B-121D-4363-8527-A5E64901CC6BQ38770799-A7BCE349-04B0-4E8A-AA54-1D4B359567B0
P2860
Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Neuroprotection of retinal gan ...... d chronic ocular hypertension.
@ast
Neuroprotection of retinal gan ...... d chronic ocular hypertension.
@en
type
label
Neuroprotection of retinal gan ...... d chronic ocular hypertension.
@ast
Neuroprotection of retinal gan ...... d chronic ocular hypertension.
@en
prefLabel
Neuroprotection of retinal gan ...... d chronic ocular hypertension.
@ast
Neuroprotection of retinal gan ...... d chronic ocular hypertension.
@en
P2093
P1476
Neuroprotection of retinal gan ...... d chronic ocular hypertension.
@en
P2093
P304
P407
P577
2001-11-01T00:00:00Z